Hypera
Hypera Pharma is one of Brazil’s largest and most diversified pharmaceutical companies, operating across all major segments of the health sector.
Company facts
- Founded
- 2001
- Employees
- 10,000
- Headquarters
- Brazil
- Type
- Enterprise
About
Hypera Pharma is one of Brazil’s largest and most diversified pharmaceutical companies, operating across all major segments of the health sector. The firm leads the Consumer Health market with well‑known over‑the‑counter brands such as Benegrip, Buscopan, Engov, Epocler, Estomazil, Neosaldina and Zero‑Cal, and also offers prescription medicines through its Mantecorp Farmasa line, dermocosmetics under Mantecorp Skincare, Simple Organic and Bioage, and a robust portfolio of generics via Neo Química. Recently, Hypera expanded into the institutional market, supplying clinics and hospitals. Headquartered in São Paulo and listed on Brazil’s Novo Mercado since 2008, Hypera employs over 3,400 professionals and is committed to sustainable growth, continuous innovation, and high‑quality, safe products. In 2023, the company joined the Brazilian Corporate Sustainability Index, reflecting its strong ESG practices and reinforcing its reputation as a responsible employer in the pharmaceutical industry.